Health & Beauty

According to Huacheng Import and Export Data Observation, International Finance Corporation (IFC), a member of the World Bank Group, announced on June 6 that it would establish a partnership with Fosun Pharma Pharmaceutical (Group) Co., Ltd. to help the company establish pharmaceutical production facilities and distribution centers in C ô te d'Ivoire, so as to help improve the health level of West Africa.

According to Huacheng Import and Export Data Observation, under this partnership, IFC will provide two loans totaling 50 million euros to the subsidiary of Fosun Pharma to build a production facility for antimalarial and antibacterial drugs near Abidjan. The facility is expected to become the largest pharmaceutical factory in C ô te d'Ivoire, with an annual drug production capacity of 5 billion tablets. The supporting distribution center will also be completed nearby.

The West African region is deeply affected by infectious and other diseases. This project will help the region obtain more high-quality and affordable life-saving drugs, thereby improving overall health levels. The project will also promote the dissemination of medical and manufacturing related knowledge to the African region, contributing to the long-term development and improvement of the health sector in the region. Huacheng Import and Export Data Observation Report.

Wu Yifang, chairman of Fosun Pharma, said: "I am very glad that Fosun Pharma Africa Cote d'Ivoire Park Project has received the support of IFC, which will help us to realize the local production and distribution of drugs in Africa. Since 2006, Fosun Pharma has received the support of IFC in finance and consulting for many times in the process of globalization. Fosun Pharma is committed to improving the accessibility and affordability of high-quality medical products in West Africa, and improving the supply of medical and health products in the region Chain elasticity

S é rgio Pimenta, the vice president of IFC Africa, said: "Strengthening the health care infrastructure and capacity building in Africa is crucial to the future social and economic development of the African continent, especially after the COVID-19 epidemic. The cooperation between IFC and Fosun Pharma will improve the local production capacity of basic drugs in West Africa, making it easier for patients in the region to access high-quality and affordable drugs."

In the past 17 years, IFC has provided funding and consulting support for Fosun Pharma, a leading pharmaceutical enterprise in China with footprints in major countries and regions around the world. As the world's largest international development agency focused on the private sector in emerging markets, IFC collaborates in over 100 countries worldwide, leveraging its financial resources, expertise, and influence to create markets and opportunities in developing countries. According to Huacheng Import and Export Data Observation, in the fiscal year 2022, IFC's committed investment in private companies and financial institutions in developing countries reached a record high of 32.8 billion US dollars.

According to Huacheng Import and Export Data Observation, Artesunate for injection developed by Fosun Pharma has cured more than 56 million severe malaria patients worldwide. As one of the world's largest manufacturers of Antimalarial medication, Fosun Pharma has become a supplier of Antimalarial medication to the Global Fund, the UNICEF, the World Health Organization (WHO) and national drug procurement centers in Africa. As a global pharmaceutical and health industry group rooted in China and driven by innovation, Fosun Pharma continues to enrich the innovative product pipeline, improve the research and clinical development capacity of new drugs, and accelerate the research and transformation of innovative technologies and products through independent research and development, cooperative development, licensing introduction, and in-depth incubation. At the same time, we focus on strengthening international cooperation, strengthening global development, actively promoting the online and offline layout of the healthcare industry, and gradually growing into an international enterprise in the global healthcare market.